A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.

Abstract

OBJECTIVE To assess the effect of mealtime amylin replacement with pramlintide on long-term glycemic and weight control in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS In a 52-week, double-blind, placebo-controlled, multicenter study, 480 patients with type 1 diabetes were randomized to receive preprandial injections of placebo or 30 microg… (More)

Topics

Cite this paper

@article{Whitehouse2002ARS, title={A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.}, author={Fred W Whitehouse and D. Kruger and Mark Fineman and Larry Z. Shen and James A. Ruggles and David G. Maggs and Christian Weyer and Orville G Kolterman}, journal={Diabetes care}, year={2002}, volume={25 4}, pages={724-30} }